USU Software AG resolves public share buyback offer
Ad hoc disclosure in accordance with Article 17 of the Market Abuse Regulation – Public…
Ad hoc disclosure in accordance with Article 17 of the Market Abuse Regulation – Public…
— Clinical trials of core drug candidates are progressing steadily with the debut of the…
ALLSCHWIL, Switzerland, Aug. 31, 2022 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical…
Internet City, Dubai–(Newsfile Corp. – August 31, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – August 31, 2022) – As a world class digital asset…
Arizona, Aug 31, 2022 – (ACN Newswire) – One of the greatest hurdles in the…
Integration will help finance professionals understand their data and make critical business decisions RALEIGH, N.C.–(BUSINESS…
SP-103 receives Fast Track Designation, which makes it eligible for some or all of the…
SINGAPORE, Aug 31, 2022 – (ACN Newswire) – Apeiron Bioenergy has successfully closed an equity…
The global semiconductor revenue is expected to reach $661 billion in 2022, up by 13.7%…
Includes offers for securities issued by United States Steel Corporation and co-issued by Big River…
At June 30, 2022, cash-on-hand was US$60.4 million with pro-forma US$105.5 million after raising gross…
HONG KONG, Aug 31, 2022 – (ACN Newswire) – China’s major furniture product manufacturer Huisen…
HONG KONG, Aug 31, 2022 – (ACN Newswire) – ESPRIT HOLDINGS LIMITED (the “Company”, together…
GTB-3650’s IND application with the FDA expected by end of first quarter of 2023 BRISBANE,…
– Topline data for anti-CTLA-4 antibody, ADG116, shows compelling clinical safety and complete and partial…
MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated…
NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
WOODCLIFF LAKE, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL),…